Peptide Synergy Matrix

Explore our comprehensive database of peptide interactions. Search for your primary compound below to review its precise synergistic stacks and critical physiological contraindications.

Semaglutide

This is the heading
FAT LOSS
The famous GLP-1 receptor agonist that regulates insulin and crushes appetite.
Works Best With
AOD9604

This combination highly accelerates lipid metabolism. While the primary compound targets fat mobilization or insulin regulation, the secondary agent directly shuttles those released fatty acids into the mitochondria for oxidation. Together, they create a multi-pathway fat-burning environment.

L-carnitine

This combination highly accelerates lipid metabolism. While the primary compound targets fat mobilization or insulin regulation, the secondary agent directly shuttles those released fatty acids into the mitochondria for oxidation. Together, they create a multi-pathway fat-burning environment.

Works Best With
Tirzepatide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Retatrutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Liraglutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Dulaglutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Dulaglutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Cagrisema (2.5mg+2.5mg)

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Cagrisema (5mg+5mg)

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Cagrisema (10mg+10mg)

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Semaglutide

This is the heading
FAT LOSS
The famous GLP-1 receptor agonist that regulates insulin and crushes appetite.
Works Best With
AOD9604

This combination highly accelerates lipid metabolism. While the primary compound targets fat mobilization or insulin regulation, the secondary agent directly shuttles those released fatty acids into the mitochondria for oxidation. Together, they create a multi-pathway fat-burning environment.

L-carnitine

This combination highly accelerates lipid metabolism. While the primary compound targets fat mobilization or insulin regulation, the secondary agent directly shuttles those released fatty acids into the mitochondria for oxidation. Together, they create a multi-pathway fat-burning environment.

Works Best With
Tirzepatide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Retatrutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Liraglutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Dulaglutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Dulaglutide

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Cagrisema (2.5mg+2.5mg)

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Cagrisema (5mg+5mg)

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Cagrisema (10mg+10mg)

Combining multiple GLP-1 or GIP receptor agonists provides no additional fat-loss benefits but drastically increases the risk of severe gastrointestinal distress, nausea, and receptor downregulation. They compete for the exact same pathways, causing extreme metabolic stress.

Frequently Asked Questions

How long does international shipping take?

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Our standard international shipping typically takes 10 to 12 days to arrive at your destination. Once your package is dispatched, you can monitor its progress using the tracking tool above.

Scroll to Top